companydata.dkcompanydata.dk

ZEALAND PHARMA A/S: Financial statements 2023

CVR: 20045078

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

ZEALAND PHARMA A/S (CVR 20045078) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 342,788,000 and a net result of DKK -703,739,000 compared with EUR -1,202,135,000 the year before. That is an increase of 229.6% compared with the year before. The profit margin was -205.3%. Equity in the 2023 report amounted to DKK 1,592,839,000. The solvency ratio was 80.4%. The company had 235 employees in the financial year.

Revenue
DKK 342,788,000
Gross Profit
DKK 323,614,000
Profit/Loss
DKK -703,739,000
Equity
DKK 1,592,839,000
Total Assets
DKK 1,979,993,000
Employees
235

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023342.8M323.6M-703.7M1.6B235
2022104M EUR104M EUR-1.2B EUR815.9M EUR247
2021292.6M173.8M-1B927.8M346
2020353.3M262.7M-846.7M1.2B297
201941.3M--571.5M1.2B-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

ZEALAND PHARMA A/S publishes interim reportNov 16, 2023

ZEALAND PHARMA A/S has published its interim report for the period January 1, 2023 to September 30, 2023.

Registered as owner of ZEALAND PHARMA A/SOct 19, 2023

As of October 19, 2023, is registered as an owner of ZEALAND PHARMA A/S with an ownership share of 5%.

ZEALAND PHARMA A/S publishes interim reportAug 22, 2023

ZEALAND PHARMA A/S has published its interim report for the period January 1, 2023 to June 30, 2023.

ZEALAND PHARMA A/S publishes interim reportJun 1, 2023

ZEALAND PHARMA A/S has published its interim report for the period January 1, 2023 to March 31, 2023.

ZEALAND PHARMA A/S: The 2022 annual report is outApr 3, 2023

ZEALAND PHARMA A/S has published its annual report for 2022. Revenue came to DKK 103,986,000, and the net result was DKK -1,202,135,000.

About ZEALAND PHARMA A/S

ZEALAND PHARMA A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1997. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ZEALAND PHARMACEUTICALS A/S and PEPTIDE PROBE TECHNOLOGIES ApS. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The board consists of Alf Gunnar Martin Nicklasson (chair), Kirsten Aarup Drejer, Adam Krisko Nygaard and Anneline Nansen. The company's owners include ZEALAND PHARMA A/S, Van Herk Investments B.V. and Van Herk Management Services B.V.. The company has 575 employees (2026). In 2025, the company reported revenue of DKK 9,214,860,000 and a net result of DKK 6,455,008,000 compared with DKK -1,078,828,000 the year before. Equity in the 2025 report amounted to DKK 14,830,613,000.

Source: annual report 2025, Danish Business Authority